Newsletter
Durable, Long Term Outcomes support improving Patient access for ReActiv8 with Chip Moebus, Vice President of Reimbursement and Market Access at Mainstay Medical

Outcomes Rocket

Durable, Long Term Outcomes support improving Patient access for ReActiv8 with Chip Moebus, Vice President of Reimbursement and Market Access at Mainstay Medical

December 15, 2022

Durable, Long Term Outcomes support improving Patient access for ReActiv8 with Chip Moebus, Vice President of Reimbursement and Market Access at Mainstay Medical

The insurance industry has to be educated about what ReActiv8 means in terms of opportunities for chronic low back pain patients.

In this episode, Chip Moebus, Vice President of Reimbursement and Market Access at Mainstay Medical, talks about the Reactiv8 therapy and the different elements that play into bringing access to these types of innovations for chronic low back pain patients; The evidence generation and patient selection criteria, the groundwork necessary to educate the payer community, what makes ReActiv8 disruptive in the field, and its economic value. Mainstay Medical’s therapy has proven durability and opioid-usage reduction results in patients.

Tune in to learn about Chip’s work to drive payer coverage, acceptance, and understanding of ReActiv8, a new solution for chronic low back pain!

Click this link to the show notes, transcript, and resources: outcomesrocket.health

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

Subscribe to Health Podcast Network

Join Our Newsletter

Proudly supported by:

cover
Nashville’s Opportunity: Eco-Action or Anxiety In this excerpt from a Climate x Health Twitter Spaces live chat, experts from Vanderbilt, Oak Ridge National Laboratory, and others discuss hope and want listeners to be energetic and reject “doomerism” while embracing reality and emphasizing teamwork without ego to accomplish individual and systemic goals. This conversation was hosted live from the AAMC conference in Nashville.